Does TREPROSTINIL Cause Infusion site induration? 598 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 598 reports of Infusion site induration have been filed in association with TREPROSTINIL (TYVASO). This represents 0.7% of all adverse event reports for TREPROSTINIL.
598
Reports of Infusion site induration with TREPROSTINIL
0.7%
of all TREPROSTINIL reports
11
Deaths
118
Hospitalizations
How Dangerous Is Infusion site induration From TREPROSTINIL?
Of the 598 reports, 11 (1.8%) resulted in death, 118 (19.7%) required hospitalization, and 6 (1.0%) were considered life-threatening.
Is Infusion site induration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 598 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Infusion site induration?
HUMAN IMMUNOGLOBULIN G (209)
FOSCARBIDOPA\FOSLEVODOPA (112)
AMBRISENTAN (49)
MACITENTAN (26)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (25)
CAPECITABINE (23)
EVEROLIMUS (22)
ZOLEDRONIC ACID (22)
PAMIDRONATE (20)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (17)
Which TREPROSTINIL Alternatives Have Lower Infusion site induration Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE